Furthermore, this adipokine is decreased in both psoriasis and obesity [123]; thus, it has been noticed that when a patient’s weight decreases, adiponectin concentrations rise, and their clinical psoriasis manifestations improve [40]. Here, ADIPOQ is linked to obesity disorder.